Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 58 clinical trials
featured
A multinational, randomized, double-blind, placebo controlled trial to evaluate the effect of Ticagrelor 90mg twice daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients with Type 2 Diabetes Mellitus.

A multinational, randomized, double-blind, placebo controlled trial to evaluate the effect of Ticagrelor 90mg twice daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in

  • 70 views
  • 23 Nov, 2020
  • 1 location
Ticagrelor De-escalation Strategy in East Asian Patients With AMI

Ticagrelor as nonthienopyridine, direct-acting P2Y12 receptor antagonist, had significantly greater platelet inhibition, which could reduce ischemic events at acute phase, however, resulting in

  • 0 views
  • 23 Feb, 2021
  • 1 location
Fentanyl and Crushed Ticagrelor in Percutaneous Coronary Intervention

During a percutaneous coronary intervention (PCI), Fentanyl is commonly used for sedation. Ticagrelor is also routinely used as anti-platelet agent during PCI. However, a recent study has

ticagrelor
  • 0 views
  • 11 Feb, 2021
  • 1 location
Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation

avoid thromboembolic complications. But the risk of bleeding events with DAPT in this population is not negligible. This study aims to determine the degree of response to Ticagrelor 60 mg every

  • 0 views
  • 05 Aug, 2021
  • 1 location
Phase 2B Study to Evaluate the Efficacy of PB2452 in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old

ticagrelor as part of a dual antiplatelet regimen and to evaluate the safety and tolerability of PB2452 in subjects aged 50-80 years old. Approximately 200 subjects between 50-80 years old will be

  • 0 views
  • 15 Jul, 2021
  • 15 locations
Ticagrelor Versus Clopidogrel in Carotid Artery Stenting

Patients with symptomatic or asymptomatic carotid stenosis in whom carotid artery stenting is planned are randomised between antiplatelet therapy with ticagrelor plus aspirin or clopidogrel plus

ticagrelor
amaurosis fugax
stroke
aspirin
clopidogrel
  • 54 views
  • 03 Feb, 2021
  • 21 locations
A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients

This study is to evaluate the safety and efficacy of 60mg ticagrelor plus 100mg Aspirin to prevent major adverse cardiovascular and cerebrovascular events in one years after drug-eluting stents

ticagrelor
acute coronary syndrome
percutaneous coronary intervention
aspirin
  • 4 views
  • 20 Jun, 2021
  • 8 locations
Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

To compare the clinical outcomes of dual antiplatelet therapy with aspirin and ticagrelor vs. ticagrelor monotherapy at 3 months after PCI in patients with acute coronary syndrome.

thrombosis
sirolimus
dapt
antiplatelet therapy
ticagrelor
  • 10 views
  • 22 Jan, 2021
  • 1 location
Ticagrelor Monotherapy in PAtients Treated With New-generation Drug-eluting Stents for Acute Coronary Syndrome; T-PASS Trial

We hypothesized that ticagrelor monotherapy might be enough to prevent thromboembolic events without aspirin after PCI in patients with acute coronary syndrome(ACS). Moreover, ticagrelor

  • 0 views
  • 25 Jan, 2021
  • 1 location
Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome

The study is a Randomised Registry-based Clinical Trial (RRCT) to assess whether dual antiplatelet therapy with ticagrelor and ASA compared to ASA alone improves outcome after isolated CABG in

unstable angina
ticagrelor
acute coronary syndrome
antiplatelet therapy
stemi
  • 6 views
  • 16 Apr, 2021
  • 30 locations